Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 10
2024
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Exercise of conversion of derivative security
|
Direct |
1,078
+12.85%
|
-
|
Feb 10
2024
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-4.0%
|
$420,980
$388.22 P/Share
|
Feb 10
2024
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
2,873
+9.58%
|
-
|
Feb 10
2024
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
222
-7.63%
|
$86,136
$388.22 P/Share
|
Feb 10
2024
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
568
+16.33%
|
-
|
Feb 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
316
-3.8%
|
$122,608
$388.22 P/Share
|
Feb 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
958
+10.32%
|
-
|
Feb 10
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
338
-1.56%
|
$131,144
$388.22 P/Share
|
Feb 10
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,078
+4.73%
|
-
|
Feb 07
2024
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
80,710
-7.88%
|
$31,396,190
$389.28 P/Share
|
Feb 07
2024
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
140,850
+12.03%
|
$7,465,050
$53.16 P/Share
|
Feb 01
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
39
-8.01%
|
$14,742
$378.41 P/Share
|
Jan 29
2024
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Indirect |
4,960
-8.31%
|
$1,855,040
$374.41 P/Share
|
Jan 29
2024
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
24,325
-72.07%
|
$9,146,200
$376.06 P/Share
|
Jan 29
2024
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,750
+50.0%
|
$1,721,250
$51.02 P/Share
|
Jan 26
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,318
-91.26%
|
$1,597,660
$370.15 P/Share
|
Jan 26
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,318
+47.71%
|
$777,240
$180.41 P/Share
|
Jan 26
2024
|
Amal M Johnson Director |
SELL
Open market or private sale
|
Direct |
6,696
-36.39%
|
$2,477,520
$370.08 P/Share
|
Jan 26
2024
|
Amal M Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,696
+26.68%
|
$374,976
$56.97 P/Share
|
Jan 26
2024
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.68%
|
$740,000
$370.2 P/Share
|
Jan 26
2024
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.45%
|
$244,000
$122.37 P/Share
|
Dec 13
2023
|
David J. Rosa President |
SELL
Bona fide gift
|
Direct |
1,572
-1.01%
|
-
|
Nov 16
2023
|
Amal M Johnson Director |
SELL
Open market or private sale
|
Direct |
9,567
-44.97%
|
$2,870,100
$300.0 P/Share
|
Nov 16
2023
|
Amal M Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,567
+31.02%
|
$392,247
$41.26 P/Share
|
Nov 16
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,819
-92.83%
|
$2,645,700
$300.0 P/Share
|
Nov 16
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,819
+48.13%
|
$1,543,325
$175.81 P/Share
|
Nov 14
2023
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,000
-7.32%
|
$580,000
$290.0 P/Share
|
Nov 14
2023
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.82%
|
$180,000
$90.49 P/Share
|
Nov 14
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
867
-5.59%
|
$251,430
$290.0 P/Share
|
Nov 14
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
867
+5.26%
|
$210,681
$243.97 P/Share
|
Oct 26
2023
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
27,385
-53.76%
|
$7,120,100
$260.11 P/Share
|
Oct 26
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,750
+39.85%
|
$1,653,750
$49.34 P/Share
|
Oct 24
2023
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Indirect |
4,960
-7.67%
|
$1,344,160
$271.93 P/Share
|
Oct 24
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,110
-4.82%
|
$301,920
$272.95 P/Share
|
Oct 24
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,110
+4.57%
|
$208,680
$188.86 P/Share
|
Oct 10
2023
|
Gary Loeb General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
904
-34.6%
|
$268,488
$297.83 P/Share
|
Oct 10
2023
|
Gary Loeb General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,613
+50.0%
|
-
|
Sep 14
2023
|
Amy L Ladd Director |
SELL
Open market or private sale
|
Direct |
500
-41.6%
|
$152,500
$305.68 P/Share
|
Aug 07
2023
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.76%
|
$620,000
$310.0 P/Share
|
Aug 07
2023
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.59%
|
$160,000
$80.9 P/Share
|
Jul 31
2023
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Indirect |
4,960
-7.13%
|
$1,612,000
$325.89 P/Share
|
Jul 28
2023
|
Gary S Guthart CEO |
SELL
Bona fide gift
|
Indirect |
16,000
-1.34%
|
-
|
Jul 28
2023
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
50,314
-74.54%
|
$16,402,364
$326.76 P/Share
|
Jul 28
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
67,500
+50.0%
|
$2,835,000
$42.64 P/Share
|
Jul 25
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
2,535
-5.46%
|
$818,805
$323.13 P/Share
|
Jul 25
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
2,535
+5.15%
|
$567,840
$224.14 P/Share
|
Jun 14
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
11,250
-31.79%
|
$3,656,250
$325.0 P/Share
|
Jun 14
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+24.12%
|
$663,750
$59.46 P/Share
|
Jun 14
2023
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
1,567
-100.0%
|
$504,574
$322.78 P/Share
|
Jun 14
2023
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,567
+50.0%
|
$64,247
$41.26 P/Share
|